Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Oral Antihyperglycemic Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
LUYE PHARMA
HUADONG MEDICINE
Jiangsu Heng Rui Medicine
TIPR Pharmaceutical
Pfizer
Sinofi
Eli Lilly
HANSOH PHARMA
AstraZeneca
HENGRUI PHARMACEUTICAL
PKU HEALTHCARE
Takeda
Novo Nordisk
By Type:
Secretagogues and Sales Growth Rate 2011-2020
DPP-4 inhibitors and Sales Growth Rate 2011-2020
Sensitizers and Sales Growth Rate 2011-2020
Alpha-glucosidase inhibitors and Sales Growth Rate 2011-2020
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Oral Antihyperglycemic Drugs Market Overview 2018-2029
-
1.1 China Oral Antihyperglycemic Drugs Industry Development Overview
-
1.2 China Oral Antihyperglycemic Drugs Industry Development History
-
1.3 China Oral Antihyperglycemic Drugs Industry Market Size (2018-2029)
-
1.4 China Oral Antihyperglycemic Drugs Market Analysis by Type from Production Side
-
1.4.1 China Oral Antihyperglycemic Drugs Production Volume, Production Value and Growth Rate of Secretagogues and Sales Growth Rate 2011-2020 (2018-2029)
-
1.4.2 China Oral Antihyperglycemic Drugs Production Volume, Production Value and Growth Rate of DPP-4 inhibitors and Sales Growth Rate 2011-2020 (2018-2029)
-
1.4.3 China Oral Antihyperglycemic Drugs Production Volume, Production Value and Growth Rate of Sensitizers and Sales Growth Rate 2011-2020 (2018-2029)
-
1.4.4 China Oral Antihyperglycemic Drugs Production Volume, Production Value and Growth Rate of Alpha-glucosidase inhibitors and Sales Growth Rate 2011-2020 (2018-2029)
-
1.5 China Oral Antihyperglycemic Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Oral Antihyperglycemic Drugs Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Oral Antihyperglycemic Drugs Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Oral Antihyperglycemic Drugs Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Oral Antihyperglycemic Drugs Market Analysis by Region
-
1.6.1 North China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Oral Antihyperglycemic Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Oral Antihyperglycemic Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Oral Antihyperglycemic Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Oral Antihyperglycemic Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Oral Antihyperglycemic Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Oral Antihyperglycemic Drugs Industry Development
Chapter 3 Oral Antihyperglycemic DrugsIndustry Chain Analysis
-
3.1 Oral Antihyperglycemic Drugs Industry Chain
-
3.2 Oral Antihyperglycemic Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Oral Antihyperglycemic Drugs Market
-
3.3 Oral Antihyperglycemic Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Oral Antihyperglycemic Drugs Market
Chapter 4 China Oral Antihyperglycemic Drugs Market, by Type
-
4.1 China Oral Antihyperglycemic Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Oral Antihyperglycemic Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Oral Antihyperglycemic Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Oral Antihyperglycemic Drugs Production Volume and Growth Rate of Secretagogues and Sales Growth Rate 2011-2020
-
4.5.2 China Oral Antihyperglycemic Drugs Production Volume and Growth Rate of DPP-4 inhibitors and Sales Growth Rate 2011-2020
-
4.5.3 China Oral Antihyperglycemic Drugs Production Volume and Growth Rate of Sensitizers and Sales Growth Rate 2011-2020
-
4.5.4 China Oral Antihyperglycemic Drugs Production Volume and Growth Rate of Alpha-glucosidase inhibitors and Sales Growth Rate 2011-2020
Chapter 5 China Oral Antihyperglycemic Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Oral Antihyperglycemic Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Oral Antihyperglycemic Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Oral Antihyperglycemic Drugs Market Size and Growth Rate of Application 1
-
5.5.2 China Oral Antihyperglycemic Drugs Market Size and Growth Rate of Application 2
-
5.5.3 China Oral Antihyperglycemic Drugs Market Size and Growth Rate of Application 3
Chapter 6 China Oral Antihyperglycemic Drugs Market, by Region
-
6.1 China Oral Antihyperglycemic Drugs Production Volume and Production Value, by Region
-
6.2 China Oral Antihyperglycemic Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Oral Antihyperglycemic Drugs Market Analysis
-
7.1 North China Oral Antihyperglycemic Drugs Market, by Type
-
7.2 North China Oral Antihyperglycemic Drugs Market, by Application
Chapter 8 Central China Oral Antihyperglycemic Drugs Market Analysis
-
8.1 Central China Oral Antihyperglycemic Drugs Market, by Type
-
8.2 Central China Oral Antihyperglycemic Drugs Market, by Application
Chapter 9 South China Oral Antihyperglycemic Drugs Market Analysis
-
9.1 South China Oral Antihyperglycemic Drugs Market, by Type
-
9.2 South China Oral Antihyperglycemic Drugs Market, by Application
Chapter 10 East China Oral Antihyperglycemic Drugs Market Analysis
-
10.1 East China Oral Antihyperglycemic Drugs Market, by Type
-
10.2 East China Oral Antihyperglycemic Drugs Market, by Application
Chapter 11 Northeast China Oral Antihyperglycemic Drugs Market Analysis
-
11.1 Northeast China Oral Antihyperglycemic Drugs Market, by Type
-
11.2 Northeast China Oral Antihyperglycemic Drugs Market, by Application
Chapter 12 Southwest China Oral Antihyperglycemic Drugs Market Analysis
-
12.1 Southwest China Oral Antihyperglycemic Drugs Market, by Type
-
12.2 Southwest China Oral Antihyperglycemic Drugs Market, by Application
Chapter 13 Northwest China Oral Antihyperglycemic Drugs Market Analysis
-
13.1 Northwest China Oral Antihyperglycemic Drugs Market, by Type
-
13.2 Northwest China Oral Antihyperglycemic Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 LUYE PHARMA
-
14.1.1 LUYE PHARMA Company Profile
-
14.1.2 LUYE PHARMA Oral Antihyperglycemic Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 HUADONG MEDICINE
-
14.2.1 HUADONG MEDICINE Company Profile
-
14.2.2 HUADONG MEDICINE Oral Antihyperglycemic Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Jiangsu Heng Rui Medicine
-
14.3.1 Jiangsu Heng Rui Medicine Company Profile
-
14.3.2 Jiangsu Heng Rui Medicine Oral Antihyperglycemic Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 TIPR Pharmaceutical
-
14.4.1 TIPR Pharmaceutical Company Profile
-
14.4.2 TIPR Pharmaceutical Oral Antihyperglycemic Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Pfizer
-
14.5.1 Pfizer Company Profile
-
14.5.2 Pfizer Oral Antihyperglycemic Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Sinofi
-
14.6.1 Sinofi Company Profile
-
14.6.2 Sinofi Oral Antihyperglycemic Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Eli Lilly
-
14.7.1 Eli Lilly Company Profile
-
14.7.2 Eli Lilly Oral Antihyperglycemic Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 HANSOH PHARMA
-
14.8.1 HANSOH PHARMA Company Profile
-
14.8.2 HANSOH PHARMA Oral Antihyperglycemic Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 AstraZeneca
-
14.9.1 AstraZeneca Company Profile
-
14.9.2 AstraZeneca Oral Antihyperglycemic Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 HENGRUI PHARMACEUTICAL
-
14.10.1 HENGRUI PHARMACEUTICAL Company Profile
-
14.10.2 HENGRUI PHARMACEUTICAL Oral Antihyperglycemic Drugs Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 PKU HEALTHCARE
-
14.11.1 PKU HEALTHCARE Company Profile
-
14.11.2 PKU HEALTHCARE Oral Antihyperglycemic Drugs Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Takeda
-
14.12.1 Takeda Company Profile
-
14.12.2 Takeda Oral Antihyperglycemic Drugs Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Novo Nordisk
-
14.13.1 Novo Nordisk Company Profile
-
14.13.2 Novo Nordisk Oral Antihyperglycemic Drugs Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Oral Antihyperglycemic Drugs Industry Research Conclusions
-
15.2 Oral Antihyperglycemic Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Oral Antihyperglycemic Drugs Industry Market Size (2018-2029)
-
Figure China Oral Antihyperglycemic Drugs Production Volume, Production Value and Growth Rate of Secretagogues and Sales Growth Rate 2011-2020 (2018-2029)
-
Figure China Oral Antihyperglycemic Drugs Production Volume, Production Value and Growth Rate of DPP-4 inhibitors and Sales Growth Rate 2011-2020 (2018-2029)
-
Figure China Oral Antihyperglycemic Drugs Production Volume, Production Value and Growth Rate of Sensitizers and Sales Growth Rate 2011-2020 (2018-2029)
-
Figure China Oral Antihyperglycemic Drugs Production Volume, Production Value and Growth Rate of Alpha-glucosidase inhibitors and Sales Growth Rate 2011-2020 (2018-2029)
-
Figure China Oral Antihyperglycemic Drugs Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Oral Antihyperglycemic Drugs Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Oral Antihyperglycemic Drugs Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Oral Antihyperglycemic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Oral Antihyperglycemic Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Oral Antihyperglycemic Drugs Market Share by Type in 2018
-
Figure China Oral Antihyperglycemic Drugs Market Share by Type in 2023
-
Figure China Oral Antihyperglycemic Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Production Volume and Growth Rate of Secretagogues and Sales Growth Rate 2011-2020 (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Production Volume and Growth Rate of DPP-4 inhibitors and Sales Growth Rate 2011-2020 (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Production Volume and Growth Rate of Sensitizers and Sales Growth Rate 2011-2020 (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Production Volume and Growth Rate of Alpha-glucosidase inhibitors and Sales Growth Rate 2011-2020 (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Market Share by Application in 2018
-
Figure China Oral Antihyperglycemic Drugs Market Share by Application in 2023
-
Figure China Oral Antihyperglycemic Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Oral Antihyperglycemic Drugs Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Oral Antihyperglycemic Drugs Production Volume by Region (2018-2023)
-
Table China Oral Antihyperglycemic Drugs Production Volume Share by Region (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Production Volume Share by Region (2018-2023)
-
Table China Oral Antihyperglycemic Drugs Production Value by Region (2018-2023)
-
Table China Oral Antihyperglycemic Drugs Production Value Share by Region (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Production Value Share by Region (2018-2023)
-
Table China Oral Antihyperglycemic Drugs Sales Volume by Region (2018-2023)
-
Table China Oral Antihyperglycemic Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Sales Volume Share by Region (2018-2023)
-
Table China Oral Antihyperglycemic Drugs Sales Value by Region (2018-2023)
-
Table China Oral Antihyperglycemic Drugs Sales Value Share by Region (2018-2023)
-
Figure China Oral Antihyperglycemic Drugs Sales Value Share by Region (2018-2023)
-
Table North China Oral Antihyperglycemic Drugs Production Volume by Type (2018-2023)
-
Table North China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Table North China Oral Antihyperglycemic Drugs Sales Volume by Application (2018-2023)
-
Table North China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Oral Antihyperglycemic Drugs Production Volume by Type (2018-2023)
-
Table Central China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Oral Antihyperglycemic Drugs Sales Volume by Application (2018-2023)
-
Table Central China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Oral Antihyperglycemic Drugs Production Volume by Type (2018-2023)
-
Table South China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Table South China Oral Antihyperglycemic Drugs Sales Volume by Application (2018-2023)
-
Table South China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Oral Antihyperglycemic Drugs Production Volume by Type (2018-2023)
-
Table East China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Table East China Oral Antihyperglycemic Drugs Sales Volume by Application (2018-2023)
-
Table East China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Oral Antihyperglycemic Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Oral Antihyperglycemic Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Oral Antihyperglycemic Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Oral Antihyperglycemic Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Oral Antihyperglycemic Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Oral Antihyperglycemic Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Oral Antihyperglycemic Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Oral Antihyperglycemic Drugs Sales Volume Share by Application (2018-2023)
-
Table LUYE PHARMA Company Profile
-
Table LUYE PHARMA Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table HUADONG MEDICINE Company Profile
-
Table HUADONG MEDICINE Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table Jiangsu Heng Rui Medicine Company Profile
-
Table Jiangsu Heng Rui Medicine Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table TIPR Pharmaceutical Company Profile
-
Table TIPR Pharmaceutical Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table Sinofi Company Profile
-
Table Sinofi Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table HANSOH PHARMA Company Profile
-
Table HANSOH PHARMA Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table HENGRUI PHARMACEUTICAL Company Profile
-
Table HENGRUI PHARMACEUTICAL Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table PKU HEALTHCARE Company Profile
-
Table PKU HEALTHCARE Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table Takeda Company Profile
-
Table Takeda Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
Table Novo Nordisk Company Profile
-
Table Novo Nordisk Oral Antihyperglycemic Drugs Revenue, Price and Gross (2018-2023)
-
